SD BIO STANDARD DIAGNOSTICS PRIVATE LIMITED

Registered Office :
AddressA-8/24, Vasant Vihar LGF, New Delhi 110 057, India
Tel. No.91-124-4367319
Mobile No.91-9971115955
NameMr. Amit Misra
Fax No.91-124-4367318
LocationLeased
WHAT IS TRUST STAMP ?
Trust Stamp is an exclusive service offered by tradeindia that provides comprehensive information of a business entity. more...
SUMMARY
Incorporated 2006/02/27
Registration No. 55 146871
No. of Employees Around 128
Line of Business Manufacturer of Rapid Test
Status Company is a relatively new & growing concern having fair trade relations. Business is active.
Litigation Clear
Auditors
Name :TR Chadha and Company, Chartered Accountant
Address:B 30, Kuthiala Building, Connaught Place, New Delhi 110 001, India
Pan No.:AAAFT1655Q

FACTORY WAREHOUSE
AddressPlot No-266, Sector-6, I.M.T. Manesar, Gurgaon - 122050, Haryana, India
Tel. No.91-124-4367319
Fax No.91-124-4367318
Area2000 Sq.ft
LocationLeased



LEGAL FORM
Private Limited Liability Company

DIRECTORS

DIRECTORS
Name :Mr. Suk Yong Lee
Designation :Director
Address :9-1505, Dong A, A.P.T., Bupyung 1, Dong, Bupyung Gu, Inchun 403 011, KO
Date of Birth/Age :1974/04/07
Pan No :ACQPL0348E
Date of Appointment :2006/05/25
Name :Mr. Won Seok Joo
Designation :Director
Address :1101 B, Baverly Park 2, Gurgaon 122 002, Haryana, India
Date of Birth/Age :1976/03/24
Date of Appointment :2007/05/25
Name :Mr. Young Shik Cho
Designation :Director
Address :H-604, Central Park 1, Sector 42, Gurgaon 1220 02, Haryana, India
Date of Birth/Age :1961/06/30
Date of Appointment :2006/02/27
Name :Mr. Jong Tae Kim
Designation :Director
Address :1101 B, Baverly Park 2, Gurgaon 122 002, Haryana, India
Date of Birth/Age :1969/03/06
Date of Ceasing :2007/05/25



MAJOR SHAREHOLDERS

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN As On (30.09.2008)
Names of ShareholdersNo. of Shares
Standard Diagnostics Inc8516905
Anigen Inc17100
Total8534005

As On (31.03.2008)
Equity Share Breakup
CategoryPercentage
Foreign holding (Foreign institutional investor(s), Foreign Companie(s) Foreign financial institutional(s), Non-resident indian(s) or Overseas corporate bodies or other)100.00



PRODUCTS DETAILS

Products:
ITC CODEProduct Description
90188018Diagnostic Tests
Rapid Test Kits for: Blood Borne Diseases, Febrile Diseases, Gastrointestinal Infections, Respiratory Diseases, Chlamydia, Rubella IgG, Tetanus, and others
Drug Abuse Test Kits: MOP, MET, AMP, COC, THC, MET/THC, MDMA, DOA Multi, Nicotine, etc.
Cancer Markers: AFP, CEA, PSA, FOB, etc.
Fertility Hormone Test Kits: hCG, LH, etc.
Forensic Test Kits: SD Semen Inspection, Blood Stain Inspection, etc.
Blood Glucose Test: SD Check Glucose Meters, SD Check Glucose Sensors,
ELISA Kits: HBsAg ELISA 3.0, Anti-HBs ELISA 3.0, HCV ELISA 3.0, HIV 1/2 ELISA 3.0, Syphilis ELISA 3.0, Malaria Ag ELISA, Malaria Ag P.F ELISA, Dengue IgG Capture ELISA, Dengue IgM Capture ELISA, Dengue NS1 Ag ELISA, etc.
Urine Test.






TRADING TERMS

Terms :
Selling :Credit Terms
Purchasing :Credit Terms


TYPE OF CUSTOMERS

Customers :
Wholesalers
Retailers




BANKERS

Bankers :
Standard Chartered BankGurgaon Branch, Haryana

AUDITORS
Name :TR Chadha and Company, Chartered Accountant
Address:B 30, Kuthiala Building, Connaught Place, New Delhi 110 001, India
Pan No.:AAAFT1655Q

FINANCIAL INFORMATION

[all figures are in Rupees Millions]

PROFIT & LOSS ACCOUNT
Particulars2008/03/31
Sales Turnover119.400
Other Income3.707
Total Income123.107
Profit/(Loss) Before Tax16.066
Provision for Taxation(0.249)
Profit/(Loss) After Tax16.315
Imports :
Raw Materials85.723
Stores & Spares1.066
Capital Goods86.789
Total Imports173.578
Expenditures :
Depreciation & Amortization6.060
Other Expenditure100.981
Total Expenditure107.041
Earnings Per Share(2.82)




CAPITAL STRUCTURE

Capital Structure AS ON (31.03.2008)

Authorised Capital :
No. of SharesTypeValueAmount
9000000Equity SharesRs.10/- EachRs.90.000 Millions

Issued, Subscribed & Paid-up Capital :
No. of SharesTypeValueAmount
8534005Equity SharesRs.10/- EachRs.85.340 Millions

NOTE:

(Above shares are held by the holding company Standard Diagnostics Inc, Korea and their nominee)




Disclaimer